Protalix BioTherapeutics PLX
NYSE PLX
$3.13 +0.28 (+9.62%)
As of: Nov 11, 2026 · 3:59 PM EST

Protalix BioTherapeutics (PLX) Long-Term Debt Repayments (2009 - 2021)

Updated

Protalix BioTherapeutics (PLX) recorded Long-Term Debt Repayments of $20.42 million in FY2024.

Analysis

Protalix BioTherapeutics (PLX) Long-Term Debt Repayments (2009 - 2021) Analysis & Trends

Starting with FY2017, Protalix BioTherapeutics' Long-Term Debt Repayments history includes 5 years.

  • Annual Long-Term Debt Repayments has a four-year compound annual growth rate of 212.2% (FY2020 to FY2024).
  • The FY2024 figure is the highest annual Long-Term Debt Repayments since FY2021.
  • Per Business Quant data, PLX's Long-Term Debt Repayments was $30.04 million in FY2021 and $215,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Protalix BioTherapeutics 230.43 Mn 59.88 Mn 14.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 4.05 Mn
Sep 30, 2021 25.99 Mn
Mar 31, 2021 4.09 Mn
Jun 30, 2018 4.74 Mn
Mar 31, 2018 11,668.00
Jun 30, 2017 4.24 Mn
Mar 31, 2017 6.73 Mn
Mar 31, 2009 -1.00 Mn
API Access

Protalix BioTherapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PLX&period=max&api_key=YOUR_API_KEY